First Amendment to the Manufacturing and Supply Agreement, dated as of September 30, 2017, by and between the Company and Vention Medical Design and Development, Inc

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Exhibit 10.2

Amendment No. 1 to Manufacturing and Supply Agreement

Amendment No. 1 to the Manufacturing and Supply Agreement, dated 30^th September 2017 (the “Amendment”) between Nevro Corp. (“Nevro”) and Vention Medical Design and Development, Inc. (“Vention”).

WHEREAS, Nevro and Vention have entered into a Manufacturing and Supply Agreement, dated December 8th, 2015 (the “Existing Agreement”).

WHEREAS, Nevro and Vention desire to amend the Existing Agreement by amending and restating Appendix B on the terms set forth herein.

NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Nevro and Vention agree as follows:

Appendix B of the Existing Agreement shall be amended and restated in its entirety to reflect the current and proposed unit costs for the Model 2000 Unit. The proposed unit cost contained in the new Appendix B will become effective for units delivered beginning on October 1, 2017. Appendix B shall be restated as follows:

APPENDIX B

9/22/2017

Model Unit Costing – Current and Proposed Unit Cost

IN WITNESS HEREOF, the parties hereto have executed this Agreement as of the date first written above.